CD8αβ Cytotoxic T-Cell Induction from Double-Positive Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing CD8αβ cytotoxic T lymphocytes from pluripotent stem cells result in cells with NK-like properties and reduced proliferative capacity, leading to potential graft versus host disease and insufficient antigen recognition, which are not suitable for effective cellular immunotherapy.
Innovation Solution
Culturing CD4/CD8 double-positive T cells in a medium containing IL-7 and a T-cell receptor activator to induce CD8αβ cytotoxic T lymphocytes, maintaining CD8αβ expression and avoiding NK activity, thereby producing cells with enhanced antigen-specific cytotoxic activity and proliferative capacity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If pluripotent stem cells are differentiated into CD8-positive T cells using conventional methods, then T cells can be produced, but the produced cells exhibit NK cell-like properties including natural killer activity, constant expression of activation molecules, and lower proliferative capacity
Solution Approach 1:
The differentiation process is divided into distinct sequential stages: first generating CD4/CD8 double-positive cells from hematopoietic progenitor cells, then selectively maturing these into CD8αβ-positive cytotoxic T lymphocytes. This segmentation allows control over the differentiation pathway to avoid NK cell phenotype acquisition while maintaining antigen-specific cytotoxicity.
Solution Approach 2:
The invention changes key differentiation parameters by using specific cytokine combinations (IL-2, IL-7, IL-15) and culture conditions that guide stem cells toward the T cell lineage while suppressing NK cell development. This parameter control ensures produced cells express CD8αβ heterodimers and maintain T cell characteristics rather than NK cell properties.
2Manufacturing precision
If conventional differentiation methods are used, then T cells are produced, but CD8 exists as αα homodimer rather than αβ heterodimer, decreasing antigen recognition capacity
Solution Approach 1:
The method establishes preliminary culture conditions with specific cytokines and growth factors during the early differentiation stages that pre-commit the developing cells to express CD8αβ heterodimers rather than αα homodimers. This preliminary action ensures correct CD8 isoform expression is established before the cells complete their maturation into cytotoxic T lymphocytes.
3Productivity
If redifferentiated CTLs are used for immunotherapy, then cytotoxic activity is achieved, but graft versus host disease risk increases due to NK cell-like properties
Solution Approach 1:
The invention extracts and eliminates the harmful NK cell-like properties from the produced T cells by controlling the differentiation pathway to exclusively generate cells with T cell phenotype. The culture conditions and cytokine regimen specifically prevent acquisition of NK cell characteristics such as natural killer activity and constant activation molecule expression, thereby removing the source of graft versus host disease risk while preserving cytotoxic function.
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method of efficiently producing cytotoxic T lymphocytes having intrinsic properties of lymphocytes of the acquired immune system suitable for cellular immunotherapy is provided. A method of producing D8α+β+ cytotoxic T lymphocytes, comprising the step of culturing CD4/CD8 double-positive T cells in a medium containing IL-7 and a T-cell receptor activator, to induce CD8α+β+ cytotoxic T lymphocytes.